Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ICT01 |
Trade Name | |
Synonyms | ICT-01|ICT 01 |
Drug Descriptions |
ICT01 is an agonistic monoclonal antibody that targets BTN3A, which leads to activation of Vgamma9Vdelta2 T lymphocytes, potentially resulting in tumor cell killing, delayed tumor growth, and enhanced antitumor immune response (PMID: 34669444). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C175508 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Aldesleukin + ICT01 | Aldesleukin ICT01 | 0 | 1 |
ICT01 | ICT01 | 0 | 1 |
ICT01 + Pembrolizumab | ICT01 Pembrolizumab | 0 | 0 |